Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

< BACK TO ARCHIVE


2020 Apr 24


Endocrine


http://www.ncbi.nlm.nih.gov/pubmed/32333268?dopt=Abstract

Soluble Klotho: a possible predictor of quality of life in acromegaly patients.

Authors

Soluble Klotho: a possible predictor of quality of life in acromegaly patients.
Coopmans EC, El-Sayed N, Frystyk J, Magnusson NE, Jørgensen J O, van der Lely A-J, Janssen JAMJL, Muhammad A, Neggers SJCMM
Endocrine. 2020 Apr 24.
PMID: 32333268.

Abstract

Although quality of life (QoL) is improved in patients with acromegaly after disease control, QoL correlates only weakly with traditional biomarkers. Our objective is to investigate a potential relation between the new serum biomarker soluble Klotho (sKlotho), GH and insulin-like growth factor 1 (IGF-1) levels, and QoL.
Read This Paper